文献速递传染病防控与疫情报告卫生政策与健康促进

抗ES24抗体口服免疫疗法减轻羔羊捻转血矛线虫感染负担与炎症

Oral immunotherapy with anti-ES24 antibodies reduces burden and fecundity of Haemonchus contortus and inflammation in lambs artificially infected.
PubMed 文献 · Vaccine · 2026-08-01

针对捻转血矛线虫多重耐药问题,本研究开发基于抗ES24抗原特异性抗体的免疫疗法,通过免疫供体羊制备纯化免疫球蛋白,体外显示降低幼虫感染性;体内实验表明治疗组羔羊虫体发育和繁殖力下降,炎症反应减轻,并增强先天与适应性免疫应答。

要点

  • 抗ES24抗体口服免疫可降低羔羊体内捻转血矛线虫的发育与繁殖力。
  • 免疫治疗显著减轻感染羔羊外周单核细胞增多和皱胃固有层中性粒细胞浸润。
  • 治疗增强局部TLR4和GAL11表达及全身淋巴细胞增多,雌性羔羊更明显。

核心结论

  • 基于抗ES24抗原特异性抗体的口服免疫疗法可减轻羔羊捻转血矛线虫感染负担、繁殖力及炎症反应,并增强免疫应答。

研究设计与样本

  • 研究通过免疫供体羊制备纯化抗ES24免疫球蛋白,体外评估幼虫感染性,并在实验感染羔羊中评价免疫治疗效果。

主要发现

  • 免疫治疗组羔羊虫体发育和繁殖力降低,外周单核细胞计数下降,皱胃固有层中性粒细胞浸润减少。
  • 治疗组羔羊局部TLR4和GAL11表达增加,全身淋巴细胞增多,尤其雌性羔羊。

临床怎么用

  • 该免疫疗法有望作为抗捻转血矛线虫的替代策略,减少对驱虫药的依赖。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Increasing multiple anthelmintic resistance in Haemonchus contortus has been reported worldwide, highlighting the need for alternative strategies to mitigate the damage caused by this nematode. In this study, we developed and evaluated an immunotherapy protocol based on specific antibodies against the ES24 antigen of H. contortus. Purified and biologically active immunoglobulins were successfully produced through the immunization of sheep donors. The purified immunoglobulins were pooled, evaluated for specific anti-ES24 levels of IgG, IgM and IgA isotypes by indirect ELISA, presenting reduced larval infectivity in vitro. In vivo, immunotherapy-treated lambs showed reduced worm development and fecundity following experimental H. contortus infection. Immunotherapy administration also significantly reduced inflammatory responses, as demonstrated by lower peripheral monocyte counts and reduced neutrophilic infiltration in the abomasal lamina propria compared to untreated infected lambs. Furthermore, treated lambs exhibited enhanced innate and adaptive immune responses, characterized locally by increased expression of TLR4 and GAL11, and systemically by lymphocytosis, particularly in female lambs. Overall, the proposed immunotherapy protocol represents a promising immunotherapy to reduce the impact of haemonchosis on sheep production, targeting antigens with low probability of developing resistance.

来源:Vaccine,查看原文。版权归原作者所有。

引用

  1. Okino CH, Mena MO, Campos EM, et al. Oral immunotherapy with anti-ES24 antibodies reduces burden and fecundity of Haemonchus contortus and inflammation in lambs artificially infected. Vaccine. 2026. PMID: 42542049. doi:10.1016/j.vaccine.2026.128976

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。